Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden
Study sponsor: Kyntra Bio
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-03-09Actual
Enrollment · participants184Actual
Source updated2024-08-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.